TAGAP Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-88406
Key Product Details
Species Reactivity
Validated:
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Summary for TAGAP Antibody
Immunogen
The immunogen is a synthetic peptide directed towards the C-terminal region of TAGAP. Peptide sequence: VHASGDSLGHVSGPGRPELLPLRTVSESVQRNKRDCLVRRCSQPVFEADQ The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for TAGAP Antibody
![Western Blot: TAGAP Antibody [NBP2-88406]](https://resources.bio-techne.com/images/products/TAGAP-Antibody-Western-Blot-NBP2-88406-img0001.jpg "Western Blot: TAGAP Antibody [NBP2-88406]")
Western Blot: TAGAP Antibody [NBP2-88406]
Western Blot: TAGAP Antibody [NBP2-88406] - WB Suggested Anti-TAGAP Antibody. Titration: 1.0 ug/ml. Positive Control: MCF7 Whole CellApplications for TAGAP Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: TAGAP
Alternate Names
FLJ32631, FLJ39771, IDDM21, MGC133247, MGC27381, TAGAP1, T-cell activation GTPase activating protein, T-cell activation GTPase-activating protein, T-cell activation Rho GTPase-activating protein, T-cell activation RhoGTPase activating protein
Gene Symbol
TAGAP
Additional TAGAP Products
Product Specific Notices for TAGAP Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...